Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$59,015,895
+$22,682,166 QoQ
Shares Held
723,500
+35.7% QoQ
Ownership
0.867%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#31
of 383 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. PTCT ranks #13 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in PTCT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $59,015,895 723,500
2026-03-31 $36,333,729 533,300
2025-12-31 $46,152,460 607,589
2025-09-30 $56,908,401 927,300
2025-06-30 $47,047,572 963,300
2025-03-31 $34,153,392 670,200
2024-12-31 $29,480,934 653,100
2024-09-30 $19,967,220 538,200
2024-06-30 $25,017,498 818,100
2024-03-31 $22,149,126 761,400
2023-12-31 $17,167,124 622,900
2023-09-30 $5,257,386 234,600
2022-09-30 $281,120 5,600
2021-12-31 $876,260 22,000
2021-09-30 $3,036,336 81,600
2021-06-30 $8,665,772 205,010
2021-03-31 $9,053,320 191,200
2020-06-30 $263,848 5,200
2020-03-31 $16,925,034 379,400